A machine learning diagnostic model for Pneumocystis jirovecii pneumonia in patients with severe pneumonia

被引:5
|
作者
Li, Xiaoqian [1 ]
Xiong, Xingyu [2 ]
Liang, Zongan [2 ]
Tang, Yongjiang [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Pneumocystis jirovecii pneumonia; Severe pneumonia; Machine learning; Diagnostic model; INFECTIOUS-DISEASES SOCIETY; CARINII-PNEUMONIA; PREVENTION; ADULTS;
D O I
10.1007/s11739-023-03353-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe diagnosis of Pneumocystis jirovecii pneumonia (PCP) in patients presenting with severe pneumonia is challenging and delays in treatment were associated with worse prognosis. This study aimed to develop a rapid, easily available, noninvasive machine learning diagnostic model for PCP among patients with severe pneumonia.MethodsA retrospective study was performed in West China Hospital among consecutive patients with severe pneumonia who had undergone bronchoalveolar lavage for etiological evaluation between October 2010 and April 2021. Factors associated with PCP were identified and four diagnostic models were established using machine learning algorithms including Logistic Regression, eXtreme Gradient Boosting, Random Forest (RF) and LightGBM. The performance of these models were evaluated by the area under the receiver operating characteristic curve (AUC).ResultsUltimately, 704 patients were enrolled and randomly divided into a training set (n = 564) and a testing set (n = 140). Four factors were ultimately selected to establish the model including neutrophil, globulin, & beta;-D-glucan and ground glass opacity. The RF model exhibited the greatest diagnostic performance with an AUC of 0.907. The calibration curve and decision curve analysis also demonstrated its accuracy and applicability.ConclusionsWe constructed a PCP diagnostic model in patients with severe pneumonia using four easily available and noninvasive clinical indicators. With satisfying diagnostic performance and good clinical practicability, this model may help clinicians to make early diagnosis of PCP, reduce the delays of treatment and improve the prognosis among these patients.
引用
收藏
页码:1741 / 1749
页数:9
相关论文
共 50 条
  • [41] Pneumocystis pneumonia:: immunosuppression, Pneumocystis jirovecii ... and the third man
    Duboucher, Christophe
    Boggia, Rosa
    Morel, Gerard
    Capron, Monique
    Pierce, Raymond J.
    Dei-Cas, Eduardo
    Viscogliosi, Eric
    NATURE REVIEWS MICROBIOLOGY, 2007, 5 (12) : 967 - 967
  • [42] Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
    Gharamti, Amal A.
    Mundo, William
    Chastain, Daniel B.
    Franco-Paredes, Carlos
    Henao-Martinez, Andres F.
    Shapiro, Leland
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [43] Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma
    Riedhammer, C.
    Duell, J.
    Kestler, C.
    Kadel, S.
    Franz, J.
    Weis, P.
    Eisele, F.
    Zhou, X.
    Steinhardt, M.
    Scheller, L.
    Mersi, J.
    Waldschmidt, J. M.
    Einsele, H.
    Turnwald, D.
    Kortuem, K. M.
    Surat, G.
    Rasche, L.
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1327 - 1332
  • [44] Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients
    Toreyin, Zehra Nur
    Ekren, Pervin
    Caner, Ayse
    Toz, Seray
    Gurgun, Alev
    Uluer, Hatice
    Bacakoglu, Feza
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [45] Pneumocystis jirovecii Pneumonia Prophylaxis for Cancer Patients during Chemotherapy
    Takeuchi, Kazuto
    Yakushijin, Yoshihiro
    PATHOGENS, 2021, 10 (02): : 1 - 7
  • [46] Serologic Responses to Pneumocystis Proteins in HIV Patients With and Without Pneumocystis jirovecii Pneumonia
    Gingo, Matthew R.
    Lucht, Lorrie
    Daly, Kieran R.
    Djawe, Kpandja
    Palella, Frank J.
    Abraham, Alison G.
    Bream, Jay H.
    Witt, Mallory D.
    Kingsley, Lawrence A.
    Norris, Karen A.
    Walzer, Peter D.
    Morris, Alison
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (03) : 190 - 196
  • [47] Pneumocystis jirovecii Pneumonia in Patients Treated for Solid Organ Malignancy
    Jackson, Ian
    Isern, Raul
    Jesina, Stephanie
    Velagapudi, Manasa
    Pruett, William
    OCHSNER JOURNAL, 2024, 24 (03): : 225 - 228
  • [48] Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series
    Franceschini, Erica
    Dolci, Giovanni
    Santoro, Antonella
    Meschiari, Marianna
    Ricco, Alice
    Menozzi, Marianna
    Burastero, Giulia Jole
    Cuffari, Biagio
    De Maria, Nicola
    Serio, Lucia
    Biagioni, Emanuela
    Catellani, Barbara
    Di Sandro, Stefano
    Colecchia, Antonio
    Girardis, Massimo
    Di Benedetto, Fabrizio
    Mussini, Cristina
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 254 - 256
  • [49] Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma
    Riedhammer, C.
    Duell, J.
    Kestler, C.
    Kadel, S.
    Franz, J.
    Weis, P.
    Eisele, F.
    Zhou, X.
    Steinhardt, M.
    Scheller, L.
    Mersi, J.
    Waldschmidt, J. M.
    Einsele, H.
    Kortuem, K. M.
    Turnwald, D.
    Surat, G.
    Rasche, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 179 - 179
  • [50] Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab
    Park, Jun Won
    Curtis, Jeffrey R.
    Jun, Kang Il
    Kim, Tae Min
    Heo, Dae Seog
    Ha, Jongwon
    Suh, Kyung-Suk
    Lee, Kwang-Woong
    Lee, Hajeong
    Yang, Jaeseok
    Kim, Min Jung
    Choi, Yunhee
    Lee, Eun Bong
    CHEST, 2022, 161 (05) : 1201 - 1210